Différences
Ci-dessous, les différences entre deux révisions de la page.
| Les deux révisions précédentes Révision précédente Prochaine révision | Révision précédente | ||
|
acupuncture:evaluation:neuro-psychiatrie:07. syndrome epaule-main post-avc [23 May 2025 16:34] Nguyen Johan [1.1. Generic Acupuncture] |
acupuncture:evaluation:neuro-psychiatrie:07. syndrome epaule-main post-avc [13 Aug 2025 17:34] (Version actuelle) Nguyen Johan [1.1. Generic Acupuncture] |
||
|---|---|---|---|
| Ligne 10: | Ligne 10: | ||
| ==== Generic Acupuncture ==== | ==== Generic Acupuncture ==== | ||
| + | |||
| + | === Gao 2025 === | ||
| + | |||
| + | Gao H, Li Z, Chen W, Shen F, Lu Y. Effectiveness of acupuncture and moxibustion combined with rehabilitation training for post-stroke shoulder-hand syndrome: a systematic review and meta-analysis. Front Neurol. 2025 Jul 28;16:1576595. https://doi.org/10.3389/fneur.2025.1576595 | ||
| + | ^Backgound| Post-stroke shoulder-hand syndrome (SHS) significantly impacts patients' quality of life and functional recovery. While both acupuncture and rehabilitation training have shown promise individually, their combined effect needs systematic evaluation.| | ||
| + | ^Methods| A comprehensive search was conducted across seven databases (PubMed, Embase, Cochrane Library, Web of Science, Sinomed, CNKI, and Wanfang) for randomized controlled trials comparing combined acupuncture-moxibustion-rehabilitation therapy vs. rehabilitation alone. The primary outcomes included Fugl-Meyer Assessment (FMA) scale, visual analog scale (VAS), and Barthel Index (BI) scores. Risk of bias was assessed using the Cochrane tool.| | ||
| + | ^Results| **Twenty-seven randomized controlled trials involving 2,175 participants** were included. Meta-analysis showed significant improvements in the combination therapy group compared to rehabilitation alone: VAS score (SMD = 1.62, 95% CI: 1.19-2.06), FMA scale (SMD = 1.78, 95% CI: 1.41-2.15), and BI/MBI scores (SMD = 1.01, 95% CI: 0.48-1.54). The combination therapy also showed superior effects on swelling reduction (SMD = -1.75, 95% CI: -2.08, -1.42) and total response rate (RR = 1.21, 95% CI: 1.01-1.44). Most studies demonstrated low to moderate risk of bias.| | ||
| + | ^Conclusion| The combination of acupuncture and moxibustion with rehabilitation training appears to be more effective than rehabilitation alone for post-stroke SHS, improving motor function, pain relief, and activities of daily living. However, high heterogeneity warrants careful interpretation and further high-quality studies.| | ||
| === Shi 2025 === | === Shi 2025 === | ||
| Ligne 129: | Ligne 137: | ||
| + | === Moxibustion === | ||
| + | |||
| + | |||
| + | == Meng 2025 == | ||
| + | |||
| + | Meng X, Sun J, Su X, Seto DJ, Wang L, Li Y, Yu H, Zhao B, Zhao J. Efficacy and safety of moxibustion treatment for upper extremity pain disorder and motor impairment in patients with stage I post-stroke shoulder-hand syndrome: a systematic review and meta-analysis of randomized controlled trials. Front Neurol. 2025 May 23;16:1530069. https://doi.org/10.3389/fneur.2025.1530069 | ||
| + | ^Backgound| Upper extremity pain disorder and motor impairment (UE-PDMI) in patients with stage I post-stroke shoulder-hand syndrome (SHS) is a common neurological comorbidity. Current interventions are with effect limitations or side effects. Moxibustion is utilized as an integrative treatment for UE-PDMI. A novel meta-analysis should be performed due to the increasing number of relevant randomized controlled trials published recently. This study aims to evaluate the efficacy and safety of moxibustion treatment for UE-PDMI.| | ||
| + | ^Methods| Eight databases, including the Cochrane Library, Embase, PubMed, Web of Science, China National Knowledge Infrastructure (CNKI), SinoMed database, China Science and Technology Journal Database (VIP) and WanFang database, were systematically searched, from their inception through May 15 2024, to identify potentially relevant randomized controlled trials (RCTs) on moxibustion for UE-PDMI in SHS patients. The data from the eligible RCTs was extracted by two independent investigators. The RevMan software (version 5.4.1) was employed for conducting the meta-analysis. The online GRADEpro tool was applied for rating the quality of evidence.| | ||
| + | ^Results| A total of **32 RCTs, involving 2,814 patients** with UE-PDMI, were included. The favorable results were considered to be reflected by reduced scores on a visual analog scale (VAS) (mean difference [MD] = -1.68, 95% CI - 2.08, -1.28, p < 0.05), improved scores on the Fugl-Meyer Assessment of the Upper Extremity (FMA-UE, MD = 8.76, 95% CI: 7.00, 10.53, p < 0.05), higher scores on the modified Barthel index (MBI, MD = 10.27, 95% CI: 6.16, 14.34, p < 0.05) or Barthel index (BI, MD = 8.06, 95% CI: 6.20, 9.91, p < 0.05), and lower scores for functional impairment on National Institute of Health Stroke Scale (NIHSS, MD = -2.34, 95% CI: -2.96, -1.72, p < 0.05) when moxibustion was combined with rehabilitation training (RT), in contrast to control groups that implemented RT alone. The better total effective rates (TERs) were achieved when moxibustion was combined with RT (risk ratio [RR] = 1.27, 95% confidence interval [CI]:1.21, 1.33, p < 0.05) or with western medicine (RR = 1.18, 95% CI: 1.02, 1.35, p = 0.02) in comparisons to corresponding control groups. There was no significant difference in the occurrence of adverse events (AEs) between corresponding experimental and control groups (RR = 1.62, 95% CI: 0.63, 4.16, p > 0.05).| | ||
| + | ^Conclusion| This study demonstrates that moxibustion as an adjuvant therapy may play a positive role in relieving pain and improving upper extremity motor function for patients with stage I SHS, given its convenience in generating prolonged effects in communities. However, a larger number of rigorously designed, pre-registered RCTs are highly needed to verify its clinical efficacy with a higher level of certainty.| | ||
